Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
143
NCT01485588
Safety and Tolerability Study for Age-Related Macular Degeneration
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 31, 2010
Completion: Mar 31, 2012
NCT02358889
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Phase: Phase 2
Start: Feb 28, 2015
Completion: Sep 30, 2016
NCT02771340
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Phase: Phase 1
Start: May 31, 2016
Completion: Sep 30, 2017
NCT03452527
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Start: Mar 26, 2018
Completion: Apr 25, 2019
NCT04369885
Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD)
Phase: N/A
Role: Collaborator
Start: Jul 1, 2020
Completion: May 24, 2021